Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(0.59)

# 3,774

Out of 4,711 analysts

3

Total ratings

n/a

Success rate

-2.31%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dev Prasad

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AVTX Avalo Therapeutics	Initiates: Buy	$24	$8.91	+169.36%	1	Dec 17, 2024
	IBIO iBio, Inc.	Initiates: Buy	$6	$2.48	+141.94%	1	Dec 17, 2024
	CALC CalciMedica	Initiates: Buy	$13	$2.76	+371.01%	1	Dec 17, 2024

Avalo Therapeutics

Dec 17, 2024

Initiates: Buy

Price Target: $24

Current: $8.91

Upside: +169.36%

iBio, Inc.

Dec 17, 2024

Initiates: Buy

Price Target: $6

Current: $2.48

Upside: +141.94%

CalciMedica

Dec 17, 2024

Initiates: Buy

Price Target: $13

Current: $2.76

Upside: +371.01%